At a glance
ClinicalIndex Comparison RecordN/ACompleted· 352 enrolled
Drug / intervention
therapeutic education programbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Development and Evaluation of a Therapeutic Education Intervention Focused on the Accession of Patients Treated With Hormonal Therapy in the Management of Breast Cancer: PEPs Hormonotherapy
In Brief
A clinical study evaluating therapeutic education program for Breast Cancer. Completed, enrolled 352 participants across 3 sites.
Detailed Summary
The purpose of this study is to evaluate the feasibility and the effectiveness of a patient education program on patients' adherence to adjuvant hormone therapy (anti-estrogen or aromatase inhibitors) for breast cancer, in collaboration with teams of sociologists, patient education and medical oncologists.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartMay 2014
First PostedNov 2014
Primary CompletionAug 2016
Study CompletionAug 2017
TodayJul 2026
First PostedNov 25, 2014
Enrollment StartMay 1, 2014
Primary CompletionAug 1, 2016
Study CompletionAug 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 11.6 years ago
Interventions
therapeutic education programbehavioral